Correction
for
Eaton, BMJ 330 (7498) 984.
BMJ 2005;330:1143 (14 May), doi:10.1136/bmj.330.7500.1143-b
Correction
Regulator restricts use of SSRIs in children
This News article by Lynn Eaton (BMJ 2005;330:984, 30 Apr) contained two inaccuracies about the drug atomoxetine. The manufacturer, Lilly, points out that we wrongly suggested that atomoxetine is an antidepressant (whereas it has no antidepressant activity). Also, atomoxetine is not associated with an increased incidence of suicide related behaviour (as we implied), although it is associated with an increased risk of hostility (as we stated) and emotional lability.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Find similar articles in ISI Web of Science
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
